60
Growth Score in past quarter
pts
Heat Score 60 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
317835
MD² is regarded as the preeminent provider of personalized medicine.
- Howard Maron: Founder & Physician
Marc Cantillon: Chief Medical OfficerPast Role: Reviva Pharmaceuticals, Chief Medical Officer
About the Company
MD²® (MD SQUARED®) in 1996 based on the belief that delivering exceptional medical care must fundamentally revolve around, honor and protect the most sacred of relationships – that between a physician and a patient. This is only possible when you limit your patient threshold to so few; 50 select families, cared for by 1 exceptional physician who is
committed to elevating their craft of medicine. This is a vow they are honored to uphold. At its finest, they believe medicine has the power to transform the lives of both patients and physicians. With this in mind, every detail and decision that went into creating MD² was intentional, highly designed, and exceedingly personal.